CliffBio
small molecule

ANASTROZOLE

ANASTROZOLE

Loss of exclusivity—loss of exclusivity
CompanyCipla →See this company's full patent-cliff portfolio

Drug detail

Brand nameANASTROZOLE
Active ingredientANASTROZOLE
Strength1MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJune 2010
Marketing statusRX

More from Cipla

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ANASTROZOLE patent cliff — loss of exclusivity — | CliffBio